Specialized Gene Therapy IRB Castle IRB’s niche in reviewing gene and cell therapy trials creates a sales opening for specialized IRB management solutions and regulatory consulting designed for ATMPs, enabling faster, compliant reviews as they scale with limited staff.

Scale through Partnerships Given a small team, Castle IRB can benefit from outsourced operations and partner services such as document management, site coordination, and workflow outsourcing to increase throughput without headcount growth.

Sabai Global Synergy As a Sabai Global subsidiary, there is cross-sell potential to integrate Castle IRB into broader research services, offering bundled solutions to biotech clients and leveraging existing Sabai relationships for rapid client acquisition.

Data Security Focus Handling sensitive human participant data in gene and cell trials requires robust security, privacy, and audit readiness; offer HIPAA-compliant cloud, security assessments, and training to meet strict regulatory expectations and reassure sponsors.

Niche Competitive Edge Position Castle IRB as a nimble, biotech-focused IRB partner that delivers rapid review cycles and expert guidance for startups and boutique sites, differentiating from larger incumbents with personalized service and gene and cell therapy know-how.